Literature DB >> 15849468

The place of the posterior surgical approach for lesions of the rectum.

T Terkivatan1, P T den Hoed, J F M Lange, V C M Koot, J J van Goch, H F Veen.   

Abstract

BACKGROUND: Although there are many advantages of a posterior approach to rectal disease, these procedures are not widely accepted because many surgeons fear the postoperative complications.
METHODS: The medical records were reviewed of 57 patients who underwent a posterior approach to the rectum between January 1980 and December 2002.
RESULTS: Twenty-eight men and 29 women with a mean age of 70.5 (range 47-83) years underwent either a posterior transsacral (n = 52) or a transsphincteric (n = 5) procedure. Indications for surgery were benign lesions (n = 33), e.g. villous adenoma, rectal prolapse and endometriosis as well as invasive adenocarcinoma (n = 24). All patients with an invasive adenocarcinoma were classified as ASA grade III or IV. Postoperative morbidity occurred in 12 patients (21%), consisting of temporary incontinence, anastomotic leakage, wound infection, and hemorrhage. There was no mortality. During a mean follow-up of 29 (range 2-86) months, 3 patients with a villous adenoma and 2 patients who were treated for a malignant lesion had a locally recurrent lesion.
CONCLUSION: We believe that a posterior approach to the rectum should be considered for various benign and selected malignant diseases, especially in case of elderly patients or patients with a compromised general condition, and has to be a part of the surgeon's armamentarium.

Entities:  

Mesh:

Year:  2005        PMID: 15849468     DOI: 10.1159/000085298

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  6 in total

1.  The use of posterior trans-sphincteric approach in surgery of the rectum: a Chinese 16-year experience.

Authors:  Hui-Zhong Qiu; Guo-Le Lin; Yi Xiao; Bin Wu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

2.  Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.

Authors:  D Centonze; E Pulvirenti; A Pulvirenti D'Urso; S Franco; N Cinardi; G Giannone
Journal:  Tech Coloproctol       Date:  2013-01-30       Impact factor: 3.781

3.  Management of a case of high-risk gastrointestinal stromal tumor in rectum by transanal minimal invasive surgery.

Authors:  Pramod Nepal; Shinichiro Mori; Yoshiaki Kita; Kan Tanabe; Kenji Baba; Yasuto Uchikado; Hiroshi Kurahara; Takaaki Arigami; Masahiko Sakoda; Kosei Maemura; Shoji Natsugoe
Journal:  World J Surg Oncol       Date:  2018-08-11       Impact factor: 2.754

4.  Transsacral approach to resect a gastrointestinal stromal tumor in the rectum: report of two cases.

Authors:  Kazuhide Matsushima; Munefumi Kayo
Journal:  Surg Today       Date:  2007-07-26       Impact factor: 2.540

5.  Impact of transanal endoscopic microsurgery on functional outcome and quality of life.

Authors:  P G Doornebosch; M P Gosselink; P A Neijenhuis; W R Schouten; R A E M Tollenaar; E J R de Graaf
Journal:  Int J Colorectal Dis       Date:  2008-04-01       Impact factor: 2.571

6.  Transsacral excision with pre-operative imatinib mesylate treatment and approach for gastrointestinal stromal tumors in the rectum: A report of two cases.

Authors:  Li-Feng Sun; Jin-Jie He; Shao-Jun Yu; Jing-Hong Xu; Jian-Wei Wang; Jun Li; Yong-Mao Song; Ke-Feng Ding; Shu Zheng
Journal:  Oncol Lett       Date:  2014-08-01       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.